Research Highlights In The News From ESMO

ESMO, cancer treatment optimization, NICHE-2 trial, SWOG S1801 trial, IPSOS trial, oncology research

The ESMO 2022 Congress took place in Paris in September 2022, with around 29,000 delegates, including 5,000 online participants. The program featured a broad range of topics, including clinical trial results, translational studies, and health policy initiatives. A key theme discussed was…

Sep 30^th • 10 mins read

US Government Payer-Funded Trials to Address Oncology's Drug-Dosing Conundrum: A Congressional Call to Action?

ORF, NCTN, dosing, clinical trials, FDA

Since the mid-20th century, cancer drug development has been driven by the "more is better" assumption, seeking the maximum tolerated dose in early trials. The FDA's Oncology Center of Excellence (OCE) Project Optimus (2021) requires dose optimization for new oncology drugs, but this does not…

Feb 13^th • 5 mins read